Development of spirulina for the manufacture and oral delivery of protein therapeutics
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The use of the edible photosynthetic cyanobacterium Arthrospira platensis (spirulina) as a biomanufacturing platform has been limited by a lack of genetic tools. Here we report genetic engineering methods for stable, high-level expression of bioactive proteins in spirulina, including large-scale, indoor cultivation and downstream processing methods. Following targeted integration of exogenous genes into the spirulina chromosome (chr), encoded protein biopharmaceuticals can represent as much as 15% of total biomass, require no purification before oral delivery and are stable without refrigeration and protected during gastric transit when encapsulated within dry spirulina. Oral delivery of a spirulina-expressed antibody targeting campylobacter—a major cause of infant mortality in the developing world—prevents disease in mice, and a phase 1 clinical trial demonstrated safety for human administration. Spirulina provides an advantageous system for the manufacture of orally delivered therapeutic proteins by combining the safety of a food-based production host with the accessible genetic manipulation and high productivity of microbial platforms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Spirulina is also being investigated as a potential edible vaccine, with one strain genetically modified to produce an antibody against campylobacter, a common cause of gastrointestinal infections in developing counties.”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Jester et al., 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another strategy for transforming spirulina is to use its xenic culture with other bacterial species that produce inhibitors of various DNases [115].”
From Spirulina/Arthrospira/Limnospira—Three Names of the Single Organism (2024) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“kmR promoter with kmR gene (kanamycin resistance); must be inserted into a ΔkmR strain.1”
From Protocol for the transformation and engineering of edible algae Arthrospira platensis to generate heterologous protein-expressing strains (2023) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The antibody within this engineered Spirulina strain has been shown to be active against this pathogen in a mouse study and is safe for human consumption (Jester et al., 2022).”
From Cyanobacteria and microalgae in supporting human habitation on Mars (2022) · cites this paper as Jester et al., 2022
The cited source says what the claim attributes to it.
In the citing paper
“harnessing the natural transformability of the edible algae Arthrospira platensis (common name: spirulina) to generate strains that express heterologous proteins”
From Protocol for the transformation and engineering of edible algae Arthrospira platensis to generate heterologous protein-expressing strains (2023) · cites this paper as Jester et al. (2022)
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 60 · Cited by 130
Research works printed but not linked: 1
- Giallourou, N. et al. A novel mouse model of Campylobacter jejuni enteropathy and diarrhea. PLoS Pathog. 14, e1007083 (2018). · DOI
Metadata
- Authors
- Jester, B. W., Zhao, H., Gewe, M., Adame, T., Perruzza, L., Bolick, D. T., Agosti, J., Khuong, N., Kuestner, R., Gamble, C., Cruickshank, K., Ferrara, J., Lim, R., Paddock, T., Brady, C., Ertel, S., Zhang, M., Pollock, A., Lee, J., Xiong, J., Tasch, M., Saveria, T., Doughty, D., Marshall, J., Carrieri, D., Goetsch, L., Dang, J., Sanjaya, N., Fletcher, D., Martinez, A., Kadis, B., Sigmar, K., Afreen, E., Nguyen, T., Randolph, A., Taber, A., Krzeszowski, A., Robinett, B., Volkin, D. B., Grassi, F., Guerrant, R., Takeuchi, R., Finrow, B., Behnke, C., & Roberts, J.
- Affiliations
- Institute for Research in Biomedicine (CH)
- University of Virginia (US)
- University of Kansas (US)
- Sandia National Laboratories California (US)
- TScan Therapeutics (United States) (US)
- Corresponding author
- Roberts, James
- ORCID
- Venue
- Nature Biotechnology
- Published
- 2022-03-21
- Volume
- 40
- Issue
- 6
- Pages
- 956-964
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- PMC
- PMC9200632
- OpenAlex
- W4221118890
- Cited by
- 130
- References
- 60
- Citations by year
- 2026: 26 · 2025: 27 · 2024: 27 · 2023: 34 · 2022: 16
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Update notices
- correction (2022-04-19)
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Biotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion, cc-by)
- KU ScholarWorks (The University of Kansas) (submittedVersion, cc-by)
- Funders
- Bill and Melinda Gates Foundation (OPP12111977, OPP1183646)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Physical Sciences › Energy › Renewable Energy, Sustainability and the Environment › Algal biology and biofuel production
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- Spirulina platensis, Spirulina, genetic engineering, protein expression, oral drug delivery, edible vaccines, Campylobacter, gastric stability
- MeSH terms
- Animals, Humans, Photosynthesis, Proteins, Biomass, Mice, Spirulina
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Development of spirulina for the manufacture and oral delivery of protein therapeutics. https://app.cochat.ai/papers/10.1038/s41587-022-01249-7
- The paper
- Jester, B. W., Zhao, H., Gewe, M., Adame, T., Perruzza, L., Bolick, D. T., Agosti, J., Khuong, N., Kuestner, R., Gamble, C., Cruickshank, K., Ferrara, J., Lim, R., Paddock, T., Brady, C., Ertel, S., Zhang, M., Pollock, A., Lee, J., . . . Roberts, J. (2022). Development of spirulina for the manufacture and oral delivery of protein therapeutics. Nature Biotechnology. https://doi.org/10.1038/s41587-022-01249-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.